308 related articles for article (PubMed ID: 27236517)
1. Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping and Histology in a Rabbit Model.
Hong YJ; Kim TK; Hong D; Park CH; Yoo SJ; Wickum ME; Hur J; Lee HJ; Kim YJ; Suh YJ; Greiser A; Paek MY; Choi BW
JACC Cardiovasc Imaging; 2016 Jul; 9(7):836-845. PubMed ID: 27236517
[TBL] [Abstract][Full Text] [Related]
2. Quantification of doxorubicin-induced interstitial myocardial fibrosis in a beagle model using equilibrium contrast-enhanced computed tomography: A comparative study with cardiac magnetic resonance T1-mapping.
Zhou Z; Xu L; Wang R; Varga-Szemes A; Durden JA; Joseph Schoepf U; Sun Z; Fan Z
Int J Cardiol; 2019 Apr; 281():150-155. PubMed ID: 30738608
[TBL] [Abstract][Full Text] [Related]
3. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
[TBL] [Abstract][Full Text] [Related]
4. Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation.
Cui Y; Cao Y; Song J; Dong N; Kong X; Wang J; Yuan Y; Zhu X; Yan X; Greiser A; Shi H; Han P
J Cardiovasc Magn Reson; 2018 Apr; 20(1):25. PubMed ID: 29681243
[TBL] [Abstract][Full Text] [Related]
5. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
[TBL] [Abstract][Full Text] [Related]
6. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
[TBL] [Abstract][Full Text] [Related]
7. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
[TBL] [Abstract][Full Text] [Related]
8. Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging.
Lee HJ; Im DJ; Youn JC; Chang S; Suh YJ; Hong YJ; Kim YJ; Hur J; Choi BW
Radiology; 2016 Jul; 280(1):49-57. PubMed ID: 27322972
[TBL] [Abstract][Full Text] [Related]
9. Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study.
Hong YJ; Park HS; Park JK; Han K; Park CH; Kim TK; Yoo SJ; Lee JY; Kim PK; Hur J; Lee HJ; Kim YJ; Suh YJ; Paek MY; Choi BW
Sci Rep; 2017 Jun; 7(1):2663. PubMed ID: 28572614
[TBL] [Abstract][Full Text] [Related]
10. Histological validation of cardiac magnetic resonance T
Zeng M; Zhang N; He Y; Wen Z; Wang Z; Zhao Y; Greiser A; An J; Zhang T; Jing B; Zhang X; Fan Z; Li D
J Magn Reson Imaging; 2016 Nov; 44(5):1179-1185. PubMed ID: 27061226
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the cardiac magnetic resonance derived extracellular volume fraction and feature tracking myocardial strain in patients with non-ischemic dilated cardiomyopathy.
Azuma M; Kato S; Kodama S; Hayakawa K; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
Magn Reson Imaging; 2020 Dec; 74():14-20. PubMed ID: 32898651
[TBL] [Abstract][Full Text] [Related]
12. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
[TBL] [Abstract][Full Text] [Related]
13. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
[TBL] [Abstract][Full Text] [Related]
14. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
Fontana M; White SK; Banypersad SM; Sado DM; Maestrini V; Flett AS; Piechnik SK; Neubauer S; Roberts N; Moon JC
J Cardiovasc Magn Reson; 2012 Dec; 14(1):88. PubMed ID: 23272651
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of non-ischemic dilated cardiomyopathy by late iodine enhancement using rapid kV switching dual-energy computed tomography: A feasibility study.
Ohta Y; Kitao S; Yunaga H; Watanabe T; Mukai-Yatagai N; Kishimoto J; Yamamoto K; Ogawa T
J Cardiovasc Comput Tomogr; 2019; 13(2):148-156. PubMed ID: 30392925
[TBL] [Abstract][Full Text] [Related]
16. Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
Al-Wakeel-Marquard N; Seidel F; Herbst C; Kühnisch J; Kuehne T; Berger F; Klaassen S; Messroghli DR
Int J Cardiol; 2021 Jun; 333():219-225. PubMed ID: 33737165
[TBL] [Abstract][Full Text] [Related]
17. Myocardial extracellular volume fraction quantification in an animal model of the doxorubicin-induced myocardial fibrosis: a synthetic hematocrit method using 3T cardiac magnetic resonance.
Zhou Z; Wang R; Wang H; Liu Y; Lu D; Sun Z; Yang G; Xu L
Quant Imaging Med Surg; 2021 Feb; 11(2):510-520. PubMed ID: 33532252
[TBL] [Abstract][Full Text] [Related]
18. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
[TBL] [Abstract][Full Text] [Related]
19. Investigation of myocardial extracellular volume fraction in heart failure patients using iodine map with rapid-kV switching dual-energy CT: Segmental comparison with MRI T1 mapping.
Ohta Y; Kishimoto J; Kitao S; Yunaga H; Mukai-Yatagai N; Fujii S; Yamamoto K; Fukuda T; Ogawa T
J Cardiovasc Comput Tomogr; 2020; 14(4):349-355. PubMed ID: 31892473
[TBL] [Abstract][Full Text] [Related]
20. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
